Convalescent plasma therapy in COVID 19: Every dark cloud has a silver lining
Author(s) -
Gopal Chawla,
Kunal Deokar,
BenhurJoel Shadrach,
Naveen Dutt
Publication year - 2020
Publication title -
journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/joacp.joacp_523_20
Subject(s) - medicine , lopinavir , hydroxychloroquine , azithromycin , convalescent plasma , covid-19 , randomized controlled trial , adverse effect , antibiotics , disease , infectious disease (medical specialty) , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom